OBJECTIVE: Chemokines coordinate leukocyte trafficking in homeostasis and during immune responses. Prior studies of their role in arthritis have used animal models with both an initial adaptive immune response and an inflammatory effector phase. We undertook analysis of chemokines and their receptors in the effector phase of arthritis using the K/BxN mouse serum-transfer model. METHODS: A time-course microarray analysis of serum-transferred arthritis was performed, examining ankle tissue, synovial fluid, and peripheral blood leukocytes. Up-regulation of chemokines was confirmed by quantitative reverse transcriptase-polymerase chain reaction. The functional relevance of chemokine induction was assessed by transferring serum into mice deficient in CCR1-7, CCR9, CXCR2, CXCR3, CXCR5, CX(3)CR1, CCL2, or CCL3. Further mechanistic analysis of CXCR2 involved treatment of arthritic mice with a CXCR2 antagonist, bone marrow (BM) cell transfers with CXCR2(+/-) and CXCR2(-/-) donors and recipients, flow cytometry of synovial cells, and competition experiments measuring enrichment of CXCR2-expressing neutrophils in arthritic joints of mice with mixed CXCR2(+/+) and CXCR2(-/-) BM cells. RESULTS: Gene expression profiling revealed up-regulation of the CXCR2 ligands CXCL1, CXCL2, and CXCL5 in the joint in parallel with disease activity. CXCR2(-/-) mice had attenuated disease relative to CXCR2(+/-) littermates, as did mice receiving the CXCR2 inhibitor, while deficiency of other chemokine receptors did not affect arthritis severity. CXCR2 was required only on hematopoietic cells and was widely expressed on synovial neutrophils. CXCR2-expressing neutrophils were preferentially recruited to arthritic joints in the presence of CXCR2-deficient neutrophils. CONCLUSION: CXCR2 (but not other chemokine receptors) is critical for the development of autoantibody-mediated arthritis, exhibiting a cell-autonomous role in neutrophil recruitment to inflamed joints.
OBJECTIVE: Chemokines coordinate leukocyte trafficking in homeostasis and during immune responses. Prior studies of their role in arthritis have used animal models with both an initial adaptive immune response and an inflammatory effector phase. We undertook analysis of chemokines and their receptors in the effector phase of arthritis using the K/BxN mouse serum-transfer model. METHODS: A time-course microarray analysis of serum-transferred arthritis was performed, examining ankle tissue, synovial fluid, and peripheral blood leukocytes. Up-regulation of chemokines was confirmed by quantitative reverse transcriptase-polymerase chain reaction. The functional relevance of chemokine induction was assessed by transferring serum into mice deficient in CCR1-7, CCR9, CXCR2, CXCR3, CXCR5, CX(3)CR1, CCL2, or CCL3. Further mechanistic analysis of CXCR2 involved treatment of arthriticmice with a CXCR2 antagonist, bone marrow (BM) cell transfers with CXCR2(+/-) and CXCR2(-/-) donors and recipients, flow cytometry of synovial cells, and competition experiments measuring enrichment of CXCR2-expressing neutrophils in arthritic joints of mice with mixed CXCR2(+/+) and CXCR2(-/-) BM cells. RESULTS: Gene expression profiling revealed up-regulation of the CXCR2 ligands CXCL1, CXCL2, and CXCL5 in the joint in parallel with disease activity. CXCR2(-/-) mice had attenuated disease relative to CXCR2(+/-) littermates, as did mice receiving the CXCR2 inhibitor, while deficiency of other chemokine receptors did not affect arthritis severity. CXCR2 was required only on hematopoietic cells and was widely expressed on synovial neutrophils. CXCR2-expressing neutrophils were preferentially recruited to arthritic joints in the presence of CXCR2-deficient neutrophils. CONCLUSION:CXCR2 (but not other chemokine receptors) is critical for the development of autoantibody-mediated arthritis, exhibiting a cell-autonomous role in neutrophil recruitment to inflamed joints.
Authors: Peter A Nigrovic; Bryce A Binstadt; Paul A Monach; Alyssa Johnsen; Michael Gurish; Yoichiro Iwakura; Christophe Benoist; Diane Mathis; David M Lee Journal: Proc Natl Acad Sci U S A Date: 2007-02-02 Impact factor: 11.205
Authors: Federico Díaz-González; Rieke H E Alten; William G Bensen; Jacques P Brown; John T Sibley; Maxime Dougados; Stefano Bombardieri; Patrick Durez; Pablo Ortiz; Gonzalo de-Miquel; Alexander Staab; Ralf Sigmund; Laurence Salin; Caroline Leledy; Stephen H Polmar Journal: Ann Rheum Dis Date: 2006-12-14 Impact factor: 19.103
Authors: A E Koch; S L Kunkel; M R Shah; S Hosaka; M M Halloran; G K Haines; M D Burdick; R M Pope; R M Strieter Journal: J Immunol Date: 1995-10-01 Impact factor: 5.422
Authors: Solomon S Shaftel; Thaddeus J Carlson; John A Olschowka; Stephanos Kyrkanides; Sarah B Matousek; M Kerry O'Banion Journal: J Neurosci Date: 2007-08-29 Impact factor: 6.167
Authors: T J Standiford; S L Kunkel; N W Lukacs; M J Greenberger; J M Danforth; R G Kunkel; R M Strieter Journal: J Immunol Date: 1995-08-01 Impact factor: 5.422
Authors: M Amat; C F Benjamim; L M Williams; N Prats; E Terricabras; J Beleta; S L Kunkel; N Godessart Journal: Br J Pharmacol Date: 2006-10-03 Impact factor: 8.739
Authors: Teresa K Tarrant; Peng Liu; Rishi R Rampersad; Denise Esserman; Lisa R Rothlein; Roman G Timoshchenko; Marcus W McGinnis; David J Fitzhugh; Dhavalkumar D Patel; Alan M Fong Journal: Arthritis Rheum Date: 2012-05
Authors: Pierre Duffau; Hanni Menn-Josephy; Carla M Cuda; Salina Dominguez; Tamar R Aprahamian; Amanda A Watkins; Kei Yasuda; Paul Monach; Robert Lafyatis; Lisa M Rice; G Kenneth Haines; Ellen M Gravallese; Rebecca Baum; Christophe Richez; Harris Perlman; Ramon G Bonegio; Ian R Rifkin Journal: Arthritis Rheumatol Date: 2015-12 Impact factor: 10.995
Authors: Adam Denes; Barry W McColl; Sophie F Leow-Dyke; Katie Z Chapman; Neil E Humphreys; Richard K Grencis; Stuart M Allan; Nancy J Rothwell Journal: J Cereb Blood Flow Metab Date: 2010-11-03 Impact factor: 6.200
Authors: Nicholas A Eisele; Hanni Lee-Lewis; Cynthia Besch-Williford; Charles R Brown; Deborah M Anderson Journal: Am J Pathol Date: 2011-03 Impact factor: 4.307
Authors: Qi-Quan Huang; Robert Birkett; Renee E Koessler; Carla M Cuda; G Kenneth Haines; Jian-Ping Jin; Harris Perlman; Richard M Pope Journal: Arthritis Rheumatol Date: 2014-01 Impact factor: 10.995
Authors: Carolyn A Lacey; Lauren L Keleher; William J Mitchell; Charles R Brown; Jerod A Skyberg Journal: J Infect Dis Date: 2016-03-06 Impact factor: 5.226
Authors: Caroline Schmutz; Alison Cartwright; Helen Williams; Oliver Haworth; John H H Williams; Andrew Filer; Mike Salmon; Christopher D Buckley; Jim Middleton Journal: Arthritis Res Ther Date: 2010-08-25 Impact factor: 5.156